Chronic B-cell dyscrasias are an important clinical feature of T-LGL leukemia

References

• Sokol L, Loughran T P, Jr. Large granular lymphocyte leukemia. Oncologist 2006; 11: 263–273
   PubMed Web of Science ®Google Scholar
• Burks E J, Loughran T P, Jr. Pathogenesis of neutropenia in large granular lymphocyte leukemia and Felty syndrome. Blood Rev 2006; 20: 245–266
   PubMed Web of Science ®Google Scholar
• Semenzato G, Pandolfi F, Chisesi T, De Rossi G, Pizzolo G, Zambello R, et al. The lymphoproliferative disease of granular lymphocytes. A heterogeneous disorder ranging from indolent to aggressive conditions. Cancer 1987; 60: 2971–2978
   PubMed Web of Science ®Google Scholar
• Wlodarski M W, Schade A E, Maciejewski J P. T-large granular lymphocyte leukemia: current molecular concepts. Hematology 2006; 11: 245–256
   PubMed Web of Science ®Google Scholar
• O'Keefe C L, Plasilova M, Wlodarski M, Risitano A M, Rodriguez A R, Howe E, et al. Molecular analysis of TCR clonotypes in LGL: a clonal model for polyclonal responses. J Immunol 2004; 172: 1960–1969
   PubMed Web of Science ®Google Scholar
• Volkheimer A D, Weinberg J B, Beasley B E, Whitesides J F, Gockerman J P, Moore J O, et al. Progressive immunoglobulin gene mutations in chronic lymphocytic leukemia: evidence for antigen-driven intraclonal diversification. Blood 2007; 109: 1559–1567
   PubMed Web of Science ®Google Scholar
• Semenzato G, Zambello R, Starkebaum G, Oshimi K, Loughran T P, Jr. The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood 1997; 89: 256–260
   PubMed Web of Science ®Google Scholar
• Wlodarski M W, O'Keefe C, Howe E C, Risitano A M, Rodriguez A, Warshawsky I, et al. Pathologic clonal cytotoxic T-cell responses: nonrandom nature of the T-cell-receptor restriction in large granular lymphocyte leukemia. Blood 2005; 106: 2769–2780
   PubMed Web of Science ®Google Scholar
• Loughran T P, Jr, Starkebaum G, Aprile J A. Rearrangement and expression of T-cell receptor genes in large granular lymphocyte leukemia. Blood 1988; 71: 822–824
   PubMed Web of Science ®Google Scholar
• Kyle R A. The monoclonal gammopathies. Clin Chem 1994; 40: 2154–2161
   PubMed Web of Science ®Google Scholar
• Airo P, Rossi G, Facchetti F, Marocolo D, Garza L, Lanfranchi A, et al. Monoclonal expansion of large granular lymphocytes with a CD4+ CD8dim+/− phenotype associated with hairy cell leukemia. Haematologica 1995; 80: 146–149
   PubMed Web of Science ®Google Scholar
• Bassan R, Pronesti M, Buzzetti M, Allavena P, Rambaldi A, Mantovani A, et al. Autoimmunity and B-cell dysfunction in chronic proliferative disorders of large granular lymphocytes/natural killer cells. Cancer 1989; 63: 90–95
   PubMed Web of Science ®Google Scholar
• Boots M A, Pegrum G D. Simultaneous presentation of chronic granulocytic leukaemia and multiple myeloma. J Clin Pathol 1982; 35: 364–365
   PubMed Web of Science ®Google Scholar
• Bourgault-Rouxel A S, Loughran T P, Jr, Zambello R, Epling-Burnette P K, Semenzato G, Donadieu J L, et al. Clinical spectrum of gamma/delta T Cell LGL leukemia: analysis of 20 cases. 2008; 32: 45–48
   Google Scholar
• Dhodapkar M V, Li C Y, Lust J A, Tefferi A, Phyliky R L. Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance?. Blood 1994; 84: 1620–1627
   PubMed Web of Science ®Google Scholar
• Fermo E, Bianchi P, Barcellini W, Pedotti P, Boschetti C, Alfinito F, et al. Immunoregulatory cytokine polymorphisms in Italian patients affected by paroxysmal nocturnal haemoglobinuria and aplastic anaemia. Eur J Immunogenet 2004; 31: 267–269
   PubMedGoogle Scholar
• Fukumoto J S, Gotlib J. A patient with paroxysmal nocturnal hemoglobinuria, T cell large granular lymphocyte clonal expansion, and monoclonal gammopathy of undetermined significance. Am J Hematol 2006; 81: 870–874
   PubMed Web of Science ®Google Scholar
• Hanada T, Ishida T, Kojima H, Tsuchiya T. Granular lymphocyte leukaemia in association with multiple myeloma. Br J Haematol 1992; 80: 127–129
   PubMed Web of Science ®Google Scholar
• Kay N E, Perri R T. Evidence that large granular lymphocytes from B-CLL patients with hypogammaglobulinemia down-regulate B-cell immunoglobulin synthesis. Blood 1989; 73: 1016–1019
   PubMed Web of Science ®Google Scholar
• Kingreen D, Dalal B I, Heyman M, Phillips G L, Horsman D, Kidd P, et al. Lymphocytosis of large granular lymphocytes in patients with Hodgkin's disease. Am J Hematol 1995; 50: 234–236
   PubMed Web of Science ®Google Scholar
• Lesesve J F, Feugier P, Lamy T, Bene M C, Gregoire M J, Lenormand B, et al. Association of B-chronic lymphocytic leukaemia and T-large granular lymphocyte leukaemia. Clin Lab Haematol 2000; 22: 121–122
   PubMedGoogle Scholar
• Marolleau J P, Henni T, Gaulard P, Le Couedic J P, Gourdin M F, Divine M, et al. Hairy cell leukemia associated with large granular lymphocyte leukemia: immunologic and genomic study, effect of interferon treatment. Blood 1988; 72: 655–660
   PubMed Web of Science ®Google Scholar
• Papadaki T, Stamatopoulos K, Kosmas C, Paterakis G, Kapsimali V, Kokkini G, et al. Clonal T-large granular lymphocyte proliferations associated with clonal B cell lymphoproliferative disorders: report of eight cases. Leukemia 2002; 16: 2167–2169
   PubMed Web of Science ®Google Scholar
• Sivakumaran M, Richards S. Immunological abnormalities of chronic large granular lymphocytosis. Clin Lab Haematol 1997; 19: 57–60
   PubMedGoogle Scholar
• Xie X Y, Sorbara L, Kreitman R J, Fukushima P I, Kingma D W, Stetler-Stevenson M. Development of lymphoproliferative disorder of granular lymphocytes in association with hairy cell leukemia. Leuk Lymphoma 2000; 37: 97–104
   PubMed Web of Science ®Google Scholar
• Yamada O, Yun-Hua W, Motoji T, Mizoguchi H. Clonal T-cell proliferation causing pure red cell aplasia in chronic B-cell lymphocytic leukaemia: successful treatment with cyclosporine following in vitro abrogation of erythroid colony-suppressing activity. Br J Haematol 1998; 101: 335–337
   PubMed Web of Science ®Google Scholar
• Papadaki T, Stamatopoulos K, Stavroyianni N, Paterakis G, Phisphis M, Stefanoudaki-Sofianatou K. Evidence for T-large granular lymphocyte-mediated neutropenia in rituximab-treated lymphoma patients: report of two cases. Leuk Res 2002; 26: 597–600
   PubMed Web of Science ®Google Scholar
• Katano H, Cohen J I. Perforin and lymphohistiocytic proliferative disorders. Br J Haematol 2005; 128: 739–750
   PubMed Web of Science ®Google Scholar
• Verbsky J W, Grossman W J. Hemophagocytic lymphohistiocytosis: diagnosis, pathophysiology, treatment, and future perspectives. Ann Med 2006; 38: 20–31
   PubMed Web of Science ®Google Scholar
• Imashuku S. Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol 2002; 44: 259–272
   PubMed Web of Science ®Google Scholar
• Imashuku S, Miyagawa A, Chiyonobu T, Ishida H, Yoshihara T, Teramura T, et al. Epstein-Barr virus-associated T-lymphoproliferative disease with hemophagocytic syndrome, followed by fatal intestinal B lymphoma in a young adult female with WHIM syndrome. Warts, hypogammaglobulinemia, infections, and myelokathexis. Ann Hematol 2002; 81: 470–473
   PubMed Web of Science ®Google Scholar
• Andersohn F, Konzen C, Garbe E. Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med 2007; 146: 657–665
   PubMed Web of Science ®Google Scholar